Titrating Tobacco Treatment Medications Using Total
Nicotine Equivalents and Expired Breath Carbon
Monoxide: A Path Increasing Quit Rates and Medical
Revenues

Mahendra Pal*

Opinion

Titrating Tobacco Treatment Medications Using Total Nicotine Equivalents and Expired Breath Carbon Monoxide: A Path Increasing Quit Rates and Medical Revenues

Matthew P Bars*

Tobacco Treatment Program, Fire Department of New York City / IntelliQuit, USA

Corresponding Author

Received Date: September 12, 2023; Published Date: September 27, 2023

Abstract

Smoking remains a persistent global public health problem, contributing significantly to preventable deaths and chronic illnesses. The addictive nature of nicotine makes quitting tobacco a formidable challenge for many individuals. While various tobacco treatment medications have been developed over the years, their effectiveness can vary greatly from person to person. Tailoring tobacco treatment therapy to individual needs is key to increasing quit rates. One promising strategy is the titration of tobacco treatment medications using Total Nicotine Equivalents (TNE) and monitoring of expired breath Carbon Monoxide (EtCO) levels. This article explores the concept of titration in tobacco treatment, exploring the significance of TNE and EtCO measurements, and discusses their implications for tobacco treatment with the goal of enhancing quit rates.

Article Details

Citation

Matthew P Bars*. Titrating Tobacco Treatment Medications Using Total Nicotine Equivalents and Expired Breath Carbon Monoxide: A Path Increasing Quit Rates and Medical Revenues. Archives in Respiratory & Pulmonary Medicine. 1(2): 2023. ARPM.MS.ID.000510.